Browse Pet Safety Reports
18,026 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 18,026 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 18,026 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| May 8, 2025 | Cat | Domestic Shorthair | Fluralaner/Moxidectin Spot-On | Application site alopecia; Application site blister; Licking at application s... | Ongoing |
| May 8, 2025 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Application site alopecia; Drug administered at inappropriate site | Ongoing |
| May 7, 2025 | Cat | Domestic Shorthair | Cefovecin | Lack of efficacy - NOS; Skin scab; Pruritus; Alopecia local; Elevated symmetr... | Ongoing |
| May 7, 2025 | Dog | Terrier - Bull - American P... | Oclacitinib Maleate | Polyuria; Polydipsia; Alopecia local; Flaking skin; Dry skin; Distension of a... | Ongoing |
| May 5, 2025 | Dog | Dog (unknown) | Lotilaner,Moxidectin,Praziquantel,Pyr... | Alopecia NOS | Outcome Unknown |
| May 4, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site alopecia | Ongoing |
| May 3, 2025 | Horse | Quarter Horse | Ceftiofur Crystalline Free Acid | Injection site irritation; Injection site pain; Injection site alopecia; Inte... | Ongoing |
| May 2, 2025 | Cat | Cat (other) | Selamectin;Sarolaner | Application site alopecia; Application site rash | Ongoing |
| May 2, 2025 | Dog | Crossbred Canine/dog | Pyrantel Pamoate;Sarolaner | Vomiting; Alopecia; Skin warmth; Underdose | Outcome Unknown |
| May 2, 2025 | Cat | Manx | Selamectin;Sarolaner | Application site alopecia; Bumps on skin; Itching | Ongoing |
| May 1, 2025 | Cat | Domestic Shorthair | Imidacloprid; Moxidectin | Application site alopecia | Ongoing |
| May 1, 2025 | Cat | Siamese | Selamectin;Sarolaner | Application site inflammation; Application site alopecia | Outcome Unknown |
| May 1, 2025 | Cat | Domestic Shorthair | Fluralaner/Moxidectin Spot-On | Application site alopecia | Ongoing |
| May 1, 2025 | Cat | Domestic Shorthair | Lotilaner | Hot spot (pyotraumatic dermatitis); Grooming disorder; Alopecia; Scratching; ... | Outcome Unknown |
| May 1, 2025 | Dog | Terrier - Scottish | Ilunocitinib | Lack of efficacy - NOS; Mass NOS; Alopecia; Neoplasia NOS | Outcome Unknown |
| Apr 30, 2025 | Dog | Chihuahua, Dog (unknown) | Pyrantel Pamoate;Sarolaner | Pinnae disorder; Alopecia local; Elevated liver enzymes NOS; Pinnal erythema;... | Outcome Unknown |
| Apr 30, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site alopecia; Application site reddening; Application site burn | Ongoing |
| Apr 30, 2025 | Cat | Russian | Selamectin;Sarolaner | Application site alopecia; Application site reddening; Skin lesion NOS | Outcome Unknown |
| Apr 30, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site alopecia; Application site pruritus; Application site bleeding | Ongoing |
| Apr 29, 2025 | Dog | Rottweiler | Fluralaner 13.64% 12-Week Chew | Emesis (multiple); Lethargy (see also Central nervous system depression in Ne... | Euthanized |
| Apr 29, 2025 | Cat | Domestic Longhair, Domestic... | Selamectin | Application site alopecia | Recovered/Normal |
| Apr 28, 2025 | Cat | Cat (other) | Frunevetmab | Skin scab; Scratching; Alopecia local; Skin lesion NOS | Outcome Unknown |
| Apr 28, 2025 | Cat | Domestic Shorthair | Praziquantel | Injection site alopecia; Injection site pain; Injection site necrosis; Other ... | Outcome Unknown |
| Apr 26, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site alopecia; Application site reddening | Ongoing |
| Apr 26, 2025 | Cat | Domestic Shorthair | Robenacoxib | Application site pruritus; Application site alopecia; Application site erythema | Outcome Unknown |
| Apr 26, 2025 | Cat | Domestic Shorthair | Maropitant Citrate | Application site pruritus; Application site alopecia; Application site erythema | Outcome Unknown |
| Apr 26, 2025 | Dog | Havanese | Trilostane | Lethargy (see also Central nervous system depression in Neurological); Pallor... | Euthanized |
| Apr 25, 2025 | Cat | Domestic Shorthair | Fluralaner/Moxidectin Spot-On | Open mouth breathing; Inappetence; Application site alopecia | Ongoing |
| Apr 25, 2025 | Dog | Terrier (unspecified), Dog ... | Bedinvetmab | Alopecia local; Crust | Ongoing |
| Apr 25, 2025 | Cat | Domestic Shorthair | Frunevetmab | Skin scab; Skin inflammation NOS; Alopecia | Ongoing |
| Apr 24, 2025 | Cat | Domestic Shorthair | Frunevetmab | Facial pruritus; Alopecia; Skin scab; Erythema (for urticaria see Immune SOC) | Ongoing |
| Apr 24, 2025 | Cat | Domestic Mediumhair | Eprinomectin; Praziquantel; Esafoxolaner | Application site alopecia; Application site pruritus; Application site erythe... | Ongoing |
| Apr 21, 2025 | Cat | Snowshoe | Frunevetmab | Fever; Cholangiohepatitis; Elevated total bilirubin; Abnormal ultrasound find... | Ongoing |
| Apr 19, 2025 | Dog | Shepherd Dog - German | Fluralaner 13.64% 12-Week Chew | Lack of efficacy (ectoparasite) - flea; Atopic allergy NOS (see also Skin); I... | Ongoing |
| Apr 19, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site alopecia; Application site inflammation; Application site ir... | Ongoing |
| Apr 18, 2025 | Cat | Domestic Shorthair | Frunevetmab | Localised itching; Moist dermatitis; Reddening of the skin; Alopecia local; S... | Ongoing |
| Apr 18, 2025 | Cat | Domestic Mediumhair | Fluralaner Spot-On Solution | Application site alopecia; Application site reddening | Ongoing |
| Apr 17, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site alopecia; Application site rash; Application site skin scaling | Outcome Unknown |
| Apr 17, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Application site alopecia | Recovered/Normal |
| Apr 16, 2025 | Dog | Retriever - Labrador | Marbofloxacin | Vomiting; Drooling; Lethargy (see also Central nervous system depression in N... | Died |
| Apr 16, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site alopecia; Application site scab | Ongoing |
| Apr 16, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site alopecia; Application site scab | Ongoing |
| Apr 15, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site alopecia; Application site scab | Ongoing |
| Apr 14, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site alopecia | Ongoing |
| Apr 13, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site alopecia | Ongoing |
| Apr 12, 2025 | Cat | Domestic Shorthair | Selamectin | Application site scratching; Excessive chewing, licking and/or grooming; Appl... | Ongoing |
| Apr 11, 2025 | Cat | Domestic Shorthair | Buprenorphine | Application site alopecia | Outcome Unknown |
| Apr 11, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Pinnal erythema; Alopecia local | Ongoing |
| Apr 11, 2025 | Cat | Domestic Longhair | Eprinomectin; Praziquantel; Esafoxolaner | Application site alopecia; Application site erythema | Recovered/Normal |
| Apr 10, 2025 | Dog | Retriever - Labrador | Bedinvetmab | Hot spot (pyotraumatic dermatitis); Elevated serum alkaline phosphatase (ALP)... | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.